FOURNEL ADVISORY ADVISED ATHENA PHARMACEUTIQUES WITH ITS CAPITAL REORGANISATION
Athena Pharmaceutiques is a recognized player in the global pharmaceutical industry, thanks to its strong commitment to the development, licensing and manufacture of solid and oral dosage forms.
Athena operates through several strategic entities worldwide, including Athena Pharmaceutiques SAS, Inpharmasci and Substina in France, and Athena DDS in India.
The transaction enables Athena to remove one of its minority shareholders from the holding company’s capital.